Low-density Lipoprotein Apheresis Therapy Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: L49C7D4EF8A2EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Low-density Lipoprotein Apheresis Therapy in Global, including the following market information:

Global Low-density Lipoprotein Apheresis Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Low-density Lipoprotein Apheresis Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Double Filtration LDL Apheresis Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Low-density Lipoprotein Apheresis Therapy include Kaneka Pharma, B.Braun, Fresenius Medical Care, Asahi Kasei Medical, Medicap, Kawasumi Laboratories, Terumo Corporation and Haemonetics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Low-density Lipoprotein Apheresis Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Low-density Lipoprotein Apheresis Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, by Type, 2021 (%)

• Double Filtration LDL Apheresis Therapy
• Cascade Filtration LDL Apheresis Therapy

Global Low-density Lipoprotein Apheresis Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, by Application, 2021 (%)

• Atherosclerosis Patient
• Obesity Patient
• Dyslipidemia Patient
• Coronary Heart Disease Patient
• Carotid Artery Disease Patient

Global Low-density Lipoprotein Apheresis Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Low-density Lipoprotein Apheresis Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Low-density Lipoprotein Apheresis Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Kaneka Pharma
• B.Braun
• Fresenius Medical Care
• Asahi Kasei Medical
• Medicap
• Kawasumi Laboratories
• Terumo Corporation
• Haemonetics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Low-density Lipoprotein Apheresis Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Low-density Lipoprotein Apheresis Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LOW-DENSITY LIPOPROTEIN APHERESIS THERAPY OVERALL MARKET SIZE

2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size: 2021 VS 2028
2.2 Global Low-density Lipoprotein Apheresis Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Low-density Lipoprotein Apheresis Therapy Players in Global Market
3.2 Top Global Low-density Lipoprotein Apheresis Therapy Companies Ranked by Revenue
3.3 Global Low-density Lipoprotein Apheresis Therapy Revenue by Companies
3.4 Top 3 and Top 5 Low-density Lipoprotein Apheresis Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Low-density Lipoprotein Apheresis Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Low-density Lipoprotein Apheresis Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Low-density Lipoprotein Apheresis Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Low-density Lipoprotein Apheresis Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Low-density Lipoprotein Apheresis Therapy Market Size Markets, 2021 & 2028
  4.1.2 Double Filtration LDL Apheresis Therapy
  4.1.3 Cascade Filtration LDL Apheresis Therapy
4.2 By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue & Forecasts
  4.2.1 By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Low-density Lipoprotein Apheresis Therapy Market Size, 2021 & 2028
  5.1.2 Atherosclerosis Patient
  5.1.3 Obesity Patient
  5.1.4 Dyslipidemia Patient
  5.1.5 Coronary Heart Disease Patient
  5.1.6 Carotid Artery Disease Patient
5.2 By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue & Forecasts
  5.2.1 By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Low-density Lipoprotein Apheresis Therapy Market Size, 2021 & 2028
6.2 By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue & Forecasts
  6.2.1 By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2028
  6.3.2 US Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.3.3 Canada Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.3.4 Mexico Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2028
  6.4.2 Germany Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.4.3 France Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.4.4 U.K. Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.4.5 Italy Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.4.6 Russia Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.4.8 Benelux Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2028
  6.5.2 China Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.5.3 Japan Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.5.4 South Korea Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.5.6 India Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2028
  6.6.2 Brazil Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.6.3 Argentina Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2028
  6.7.2 Turkey Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.7.3 Israel Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028
  6.7.5 UAE Low-density Lipoprotein Apheresis Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Kaneka Pharma
  7.1.1 Kaneka Pharma Corporate Summary
  7.1.2 Kaneka Pharma Business Overview
  7.1.3 Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Major Product Offerings
  7.1.4 Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2017-2022)
  7.1.5 Kaneka Pharma Key News
7.2 B.Braun
  7.2.1 B.Braun Corporate Summary
  7.2.2 B.Braun Business Overview
  7.2.3 B.Braun Low-density Lipoprotein Apheresis Therapy Major Product Offerings
  7.2.4 B.Braun Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2017-2022)
  7.2.5 B.Braun Key News
7.3 Fresenius Medical Care
  7.3.1 Fresenius Medical Care Corporate Summary
  7.3.2 Fresenius Medical Care Business Overview
  7.3.3 Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Major Product Offerings
  7.3.4 Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2017-2022)
  7.3.5 Fresenius Medical Care Key News
7.4 Asahi Kasei Medical
  7.4.1 Asahi Kasei Medical Corporate Summary
  7.4.2 Asahi Kasei Medical Business Overview
  7.4.3 Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Major Product Offerings
  7.4.4 Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2017-2022)
  7.4.5 Asahi Kasei Medical Key News
7.5 Medicap
  7.5.1 Medicap Corporate Summary
  7.5.2 Medicap Business Overview
  7.5.3 Medicap Low-density Lipoprotein Apheresis Therapy Major Product Offerings
  7.5.4 Medicap Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2017-2022)
  7.5.5 Medicap Key News
7.6 Kawasumi Laboratories
  7.6.1 Kawasumi Laboratories Corporate Summary
  7.6.2 Kawasumi Laboratories Business Overview
  7.6.3 Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Major Product Offerings
  7.6.4 Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2017-2022)
  7.6.5 Kawasumi Laboratories Key News
7.7 Terumo Corporation
  7.7.1 Terumo Corporation Corporate Summary
  7.7.2 Terumo Corporation Business Overview
  7.7.3 Terumo Corporation Low-density Lipoprotein Apheresis Therapy Major Product Offerings
  7.7.4 Terumo Corporation Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2017-2022)
  7.7.5 Terumo Corporation Key News
7.8 Haemonetics
  7.8.1 Haemonetics Corporate Summary
  7.8.2 Haemonetics Business Overview
  7.8.3 Haemonetics Low-density Lipoprotein Apheresis Therapy Major Product Offerings
  7.8.4 Haemonetics Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2017-2022)
  7.8.5 Haemonetics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Low-density Lipoprotein Apheresis Therapy Market Opportunities & Trends in Global Market
Table 2. Low-density Lipoprotein Apheresis Therapy Market Drivers in Global Market
Table 3. Low-density Lipoprotein Apheresis Therapy Market Restraints in Global Market
Table 4. Key Players of Low-density Lipoprotein Apheresis Therapy in Global Market
Table 5. Top Low-density Lipoprotein Apheresis Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Low-density Lipoprotein Apheresis Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Low-density Lipoprotein Apheresis Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Low-density Lipoprotein Apheresis Therapy Product Type
Table 9. List of Global Tier 1 Low-density Lipoprotein Apheresis Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Low-density Lipoprotein Apheresis Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Low-density Lipoprotein Apheresis Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Low-density Lipoprotein Apheresis Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Low-density Lipoprotein Apheresis Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Low-density Lipoprotein Apheresis Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Kaneka Pharma Corporate Summary
Table 31. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 32. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), (2017-2022)
Table 33. B.Braun Corporate Summary
Table 34. B.Braun Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 35. B.Braun Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Fresenius Medical Care Corporate Summary
Table 37. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 38. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Asahi Kasei Medical Corporate Summary
Table 40. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 41. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Medicap Corporate Summary
Table 43. Medicap Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 44. Medicap Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Kawasumi Laboratories Corporate Summary
Table 46. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 47. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Terumo Corporation Corporate Summary
Table 49. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 50. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Haemonetics Corporate Summary
Table 52. Haemonetics Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 53. Haemonetics Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Low-density Lipoprotein Apheresis Therapy Segment by Type in 2021
Figure 2. Low-density Lipoprotein Apheresis Therapy Segment by Application in 2021
Figure 3. Global Low-density Lipoprotein Apheresis Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Low-density Lipoprotein Apheresis Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Low-density Lipoprotein Apheresis Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue in 2021
Figure 8. By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
Figure 12. US Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
Figure 24. China Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. B.Braun Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medicap Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Haemonetics Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)